A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3906404)

Published in Hum Vaccin Immunother on June 04, 2013

Authors

Hu Liu1, Shuang Geng2, Congcong Feng1, Xiaoping Xie1, Bing Wu1, Xuan Chen1, Qiang Zou1, Shuang Wang1, Jiantao Cui3, Rui Xing3, Wenmei Li3, Youyong Lu3, Bin Wang4

Author Affiliations

1: State Key Laboratory for Agro-Biotechnology; College of Biological Science; China Agricultural University; Beijing, P.R. China.
2: Key Laboratory of Medical Molecular Virology of MOH and MOE; Fudan University Shanghai Medical College; Shanghai, P.R. China.
3: Laboratory of Molecular Oncology; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education); Peking University Cancer Hospital & Institute; Beijing, P.R. China.
4: State Key Laboratory for Agro-Biotechnology; College of Biological Science; China Agricultural University; Beijing, P.R. China; Key Laboratory of Medical Molecular Virology of MOH and MOE; Fudan University Shanghai Medical College; Shanghai, P.R. China.

Articles cited by this

Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol (2012) 7.39

Immunological aspects of cancer chemotherapy. Nat Rev Immunol (2008) 6.61

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc Natl Acad Sci U S A (2004) 4.70

Systematic analysis of human protein complexes identifies chromosome segregation proteins. Science (2010) 4.69

DNA vaccines: ready for prime time? Nat Rev Genet (2008) 4.10

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol (2000) 2.54

From genes to drugs: targeted strategies for melanoma. Nat Rev Cancer (2012) 2.46

DNA vaccines: progress and challenges. J Immunol (2005) 2.34

Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol (2011) 2.25

DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer (2008) 2.23

Modeling the adaptive immune system: predictions and simulations. Bioinformatics (2007) 1.95

Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines (2012) 1.44

DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther (2009) 1.34

MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One (2011) 1.31

Enhancement of immune responses to an HBV DNA vaccine by electroporation. Vaccine (2005) 1.27

Progress and prospects: the design and production of plasmid vectors. Gene Ther (2009) 1.22

Electroporation for DNA immunization: clinical application. Expert Rev Vaccines (2010) 1.21

A melanoma molecular disease model. PLoS One (2011) 1.15

Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors. J Immunol (2012) 1.14

DNA vaccines: developing new strategies against cancer. J Biomed Biotechnol (2010) 1.12

Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data. Clin Cancer Res (2011) 1.11

Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine. Cancer Res (1999) 1.06

Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms. J Leukoc Biol (2012) 1.03

Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer. Oncogene (2007) 1.00

DNA vaccines for the treatment of prostate cancer. Expert Rev Vaccines (2010) 0.91

Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model. Vaccine (2010) 0.89

Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PLoS One (2010) 0.88

Expression, purification from inclusion bodies, and crystal characterization of a transition state analog complex of arginine kinase: a model for studying phosphagen kinases. Protein Sci (1997) 0.87

p42.3 gene expression in gastric cancer cell and its protein regulatory network analysis. Theor Biol Med Model (2012) 0.84

The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. J Immunol (2000) 0.82

Cell cycle-dependent expression of p42.3 promotes mitotic progression in malignant transformed cells. Mol Carcinog (2012) 0.82

DNA vaccination strategies for anti-tumour effective gene therapy protocols. Cancer Immunol Immunother (2010) 0.81

CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination. J Gene Med (2010) 0.80